ScreenerHero

XCURExicure, Inc.

NAS · US · Healthcare · Biotechnology · exicuretx.com
1.150USD-20.69%Mkt Cap: 7.53M $P/E: —

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiot…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap7.53M $
Enterprise Value5.39M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-4.95M $
Revenue/Share—
Last Price1.150 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.69
PEG—
EV/EBITDA-0.64
EV/Revenue—
P/S—
P/B3.95
EPS (TTM)-1.17
EPS (Forward)-0.77
52W Range
1.0701% of range9.480
52W High9.480 USD
52W Low1.070 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-125.98%
ROA-35.23%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.55M $
CapEx (TTM)1.00K $
FCF Margin—
FCF Yield-51.52%
Net Debt-2.58M $
Net Debt/EBITDA0.31
Balance Sheet
Debt/Equity0.04
Current Ratio0.79
Quick Ratio0.60
Book Value/Sh0.3290 USD
Cash/Share0.4090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateAug 28, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.55M
Float2.92M
Insiders42.59%
Institutions2.31%
Short Interest
Short Ratio0.1d
Short % Float3.53%
Short % Out.1.69%
Shares Short107.47K
Short (prev mo.)6.73K
Technical
SMA 501.870 (-38.5%)
SMA 2003.702 (-68.9%)
Beta3.66
S&P 52W Chg18.16%
Avg Vol (30d)386.24K
Avg Vol (10d)37.26K
Technical Indicators
RSI (14)30.9
MACD-0.1854
MACD Signal-0.1952
MACD Hist.+0.0098
BB Upper1.862 USD
BB Middle1.490 USD
BB Lower1.118 USD
BB Width49.93%
ATR (14)0.1876 USD
Vol Ratio (20d)3.64x